🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting news! Porta Sophia's manuscript was accepted by Journal of Studies on Alcohol and Drugs, "Intellectual Property of Psychedelics for Addiction Treatment: Enabling Access and Protecting Innovation Opportunities Through Preserving the Public Domain." Check it out here: jsad.com/doi/10.15288/j…

@sigdoc So proud to see our TCID undergrad, Vignesh, take the top prize for research. KSU Radow College of Humanities & Social Sciences

📢 𝗝𝘂𝘀𝘁 𝗮𝗱𝗱𝗲𝗱 𝗳𝗼𝗿 𝗦𝗽𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟰: PRWR 6520 Creative Nonfiction Writing I with Dr. Amanda Pratt! #getyourwriteon ➡️ Register today! #kennesawstate #mapw #creativewriting #creativenonfiction #writing

💫MAPW Faculty Spotlight💫 Dr. Amanda Pratt co-wrote an article published in American Institute of the History of Pharmacy! Congratulations, Dr. Pratt! #getyourwriteon  📖 More info: hopp.uwpress.org/content/65/1/1… #kennesawstate #PsychedelicRhetoric #PsychedelicHistory #PsychedelicPatents #PsychedelicIP #PortaSophia

I need a new headshot. But I’ll be sad to leave behind my backwards hat at devils lake era… anyway, was a pleasure to participate in programming for the 3rd annual Center for Research in Psychoactive Substances psychedelic symposium, and to share about my work with Porta Sophia | Psychedelic Prior Art Library !

💫MAPW Faculty Spotlight 💫 Dr. Amanda Pratt co-wrote an article published in 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘚𝘵𝘶𝘥𝘪𝘦𝘴 𝘰𝘯 𝘈𝘭𝘤𝘰𝘩𝘰𝘭 𝘢𝘯𝘥 𝘋𝘳𝘶𝘨𝘴! Congratulations, Dr. Pratt! #getyourwriteon 📖 More info: pubmed.ncbi.nlm.nih.gov/37796629/ #kennesawstate #mapw #facultysuccess

A "Critical Psychedelic Studies" symposium at Petrie-Flom Center's "Bill of Health" is the 1st major psychedelic humanities project to launch at Harvard University since it received a $16 million grant. I describe the field's "critical turn" in this introduction. blog.petrieflom.law.harvard.edu/2024/01/29/int…

Social media inception! Check out Kennesaw State English Department Insta-post of Dr. amanda rose pratt, phd and her adventure with first-year scholars as they visit Purdue University's Betsy Gordan Psychoactive Substances Research Collection. instagram.com/reel/C225iQmRV…

Glad to see our work published in this Harvard University Petrie-Flom Center symposium on critical psychedelic studies / correcting the hype. Always a pleasure to collaborate with the brilliant Shahin Shams 🏰⚔️🐉 & TY to guest editor Neşe Devenot, PhD 🍉 (@NeseLSD.bsky.social) 💞 blog.petrieflom.law.harvard.edu/2024/02/14/bey…

One of the official complaints about the Oregon psilocybin programme. Facilitator put too much Phish on the playlist. Think we can all sympathize with this one.

Read the series on Critical #Psychedelic Studies from Neşe Devenot, PhD 🍉 (@NeseLSD.bsky.social) & Chloe Reichel. Via Petrie-Flom Center Harvard Law School. Articles by Caroline Hayes, Patric Plesa, DavidHerzberg Eiko Fried Michiel van Elk Ariel Clark kayla greenstien Tahlia Harrison, MA, MFTA, LMT amanda rose pratt, phd & more. blog.petrieflom.law.harvard.edu/symposia/criti…

💫MAPW Faculty Spotlight 💫 Dr. Amanda Pratt (amanda rose pratt, phd) co-wrote an article published in Petrie-Flom Center! Congratulations, Dr. Pratt! #getyourwriteon 📖 More info: blog.petrieflom.law.harvard.edu/2024/02/14/bey… #kennesawstate #PsychedelicRhetoric #PsychedelicHistory #PsychedelicPatents

The FDA has announced procedures for submitting testimony to the 6/4 advisory committee meeting on Lykos' MDMA-assisted therapy application. Written comments can be confidential. Requests for oral presentations should be directed to Joyce Frimpong by 5/17. federalregister.gov/documents/2024…

FDA has officially posted notice of Advisory Committee for MDMA-PT and instructions on how to proceed to submit comments or present at the meeting: federalregister.gov/documents/2024…

Thrilled to share some news! 🎉🎉 I'll be speaking at RSA 2024 Conference on May 22 - 26, 2024. I would love to see you there! - via #Whova Event Platform tinyurl.com/23h6z5hm

Very good, very correct

BREAKING: In 9-2 Vote, AdComm Finds Available Data Insufficient to Show MDMA-AT Effective in PTSD Verbatim question: Do the available data show that the drug is effective in patients with posttraumatic stress disorder? 2 Yes / 9 No

BREAKING: Benefits Do Not Outweigh Risks, AdComm Finds in 10-1 Vote Verbatim question: Do the benefits of midomafetamine with FDA’s proposed risk evaluation and mitigation strategy (REMS) outweigh its risks for the treatment of patients with PTSD? 1 Yes / 10 No

🧵Trump surrendering tonight's Q&A to 30 minutes of his fave songs while standing on stage, awkwardly conducting at times, echoes MANY instances of cultic leaders who, exhausted, ill, and at the end of their cognitive rope, outsource their emotional dominance subroutines... /1

Direct link to register here!: events.teams.microsoft.com/event/77afd307…